Delivery Order SPE2DB24D3013-SPE2DB25FFNSL
Award Date 7/25/25
Potential Completion Date 7/28/25
Potential Value $8.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zileuton ER 600 mg tablets (120 count) with a ceiling value of $4,620.21. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion by August 7, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- This is a $5,023.14 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZILEUTON ER 600 MG TABLET 120S, a pharmaceutical product, with a performance period ending on July 1, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,705.93 to AmerisourceBergen Drug Corp on July 14, 2025, with an ultimate completion date of July 15, 2025. The delivery order (4568785087) is for pharmaceutical products specified as "DT 1C 2.25X4 700/RL 6RL/BX DHAPCL," to be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price, non-set-aside contract awarded through competitive procurement, consistent with...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,496.63 on July 28, 2025, with a completion date of July 29, 2025. This non-set-aside contract procures VEOZAH 45 mg tablets in a 30-count package under a firm fixed-price arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count packaging) with a ceiling value of $1,573.01. This firm fixed-price delivery order is scheduled for ultimate completion by July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation applied. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Linezolid 600 mg tablets in quantities of 20 units. This order, valued at $1,129.06 with a firm fixed price structure, represents a non-competed delivery against an existing contract vehicle and is scheduled for completion by August 26, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Lazicluze 240 mg tablets (30-count units) with a ceiling value of $12,446.16. This firm fixed-price delivery order, with an ultimate completion date of July 9, 2025, represents a non-competitive set-aside transaction executed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a $12,449.18 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Lazcluze 80 mg, with performance at the company's headquarters in Conshohocken, Pennsylvania, and completion targeted for September 30, 2025. This non-set-aside contract was competitively awarded on September 9, 2025, under firm fixed pricing terms and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order is executed...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,257.70 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The contract follows a competitive procurement process, consistent with AmerisourceBergen's established...
- The Defense Logistics Agency awarded a $1,584.34 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed-price, non-competitive delivery order is set to be completed by August 19, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's...